- Home
- IPHA vs MYO Comparison
IPHA vs MYO Comparison
Compare IPHA & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- MYO
- Stock Information
- Founded
- IPHA 1999
- MYO 2004
- Country
- IPHA France
- MYO United States
- Employees
- IPHA N/A
- MYO N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- MYO Industrial Specialties
- Sector
- IPHA Health Care
- MYO Health Care
- Exchange
- IPHA Nasdaq
- MYO Nasdaq
- Market Cap
- IPHA 160.1M
- MYO 153.0M
- IPO Year
- IPHA 2019
- MYO 2017
- Fundamental
- Price
- IPHA $1.97
- MYO $4.37
- Analyst Decision
- IPHA Strong Buy
- MYO Strong Buy
- Analyst Count
- IPHA 1
- MYO 4
- Target Price
- IPHA $11.50
- MYO $9.75
- AVG Volume (30 Days)
- IPHA 28.5K
- MYO 301.7K
- Earning Date
- IPHA 03-27-2025
- MYO 05-07-2025
- Dividend Yield
- IPHA N/A
- MYO N/A
- EPS Growth
- IPHA N/A
- MYO N/A
- EPS
- IPHA N/A
- MYO N/A
- Revenue
- IPHA $20,831,349.00
- MYO $32,551,198.00
- Revenue This Year
- IPHA $220.44
- MYO $32.15
- Revenue Next Year
- IPHA $81.85
- MYO $17.59
- P/E Ratio
- IPHA N/A
- MYO N/A
- Revenue Growth
- IPHA N/A
- MYO 69.17
- 52 Week Low
- IPHA $1.29
- MYO $2.51
- 52 Week High
- IPHA $3.51
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- IPHA 53.30
- MYO 40.76
- Support Level
- IPHA $1.81
- MYO $4.21
- Resistance Level
- IPHA $2.00
- MYO $4.62
- Average True Range (ATR)
- IPHA 0.14
- MYO 0.34
- MACD
- IPHA 0.02
- MYO -0.01
- Stochastic Oscillator
- IPHA 53.76
- MYO 41.34
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).